CPHI vs SPGI · rev $4.1M vs P/E 27, rev $15.34B
China Pharma Holdings Inc (CPHI) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
CPHI currently screens at market cap $29.0M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the CPHI and SPGI stock pages for the full models.
Not investment advice.